Filing Details

Accession Number:
0001209191-15-084223
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-09 16:02:38
Reporting Period:
2015-12-07
Filing Date:
2015-12-09
Accepted Time:
2015-12-09 16:02:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293971 Bluebird Bio Inc. BLUE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578408 Nick Leschly C/O Bluebird Bio, Inc.
150 Second Street
Cambridge MA 02141
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-07 32,391 $2.09 278,912 No 4 M Direct
Common Stock Acquisiton 2015-12-07 28,994 $2.09 307,906 No 4 M Direct
Common Stock Acquisiton 2015-12-07 5,335 $5.50 313,241 No 4 M Direct
Common Stock Acquisiton 2015-12-08 4,901 $51.25 12,405 No 4 P Indirect Nick Leschly 2001 Trust
Common Stock Acquisiton 2015-12-08 4,781 $52.26 17,186 No 4 P Indirect Nick Leschly 2001 Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 P Indirect Nick Leschly 2001 Trust
No 4 P Indirect Nick Leschly 2001 Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-12-07 5,335 $0.00 5,335 $5.50
Common Stock Stock Option (right to buy) Disposition 2015-12-07 32,391 $0.00 32,391 $2.09
Common Stock Stock Option (right to buy) Disposition 2015-12-07 28,994 $0.00 28,994 $2.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
259,934 2023-01-16 No 4 M Direct
0 2021-07-13 No 4 M Direct
9,611 2022-06-04 No 4 M Direct
Footnotes
  1. This option to purchase shares of our common stock granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.
  2. This option vests over a four-year period, at a rate of twenty-five percent (25%) on April 15, 2012 and in 36 equal monthly installments thereafter
  3. This option vests over a four-year period, at a rate of twenty-five percent (25%) on May 1, 2013 and in 36 equal monthly installments thereafter.